Long-Term Control of Ambulatory Hypertension in Children: Improving With Time But Still Not Achieving New Blood Pressure Goals

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F13%3A10209738" target="_blank" >RIV/00064203:_____/13:10209738 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/13:10209738 RIV/00216208:11140/13:10209738

Výsledek na webu

<a href="http://dx.doi.org/10.1093/ajh/hpt048" target="_blank" >http://dx.doi.org/10.1093/ajh/hpt048</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1093/ajh/hpt048" target="_blank" >10.1093/ajh/hpt048</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Long-Term Control of Ambulatory Hypertension in Children: Improving With Time But Still Not Achieving New Blood Pressure Goals

Popis výsledku v původním jazyce

Short-term therapy can decrease blood pressure (BP) to less than the 95th percentile in only about 50% of children. The aim of our study was to investigate the long-term control of hypertension (HT) in children using ambulatory BP monitoring (ABPM). We analyzed data from all children who started ramipril monotherapy in our center. Controlled HT was defined according to the most current guidelines as systolic and diastolic BP at daytime and nighttime < 90th percentile in primary HT and < 75th percentilein renoparenchymal HT. Thirty-eight children who were on therapy 1 year were included. Thirty-two children had renoparenchymal, and 6 had primary HT. The median age at the beginning of therapy was 13.6 years (range 4.118.0 years), and the median time ofantihypertensive therapy was 2.6 years (range 1.011.8 years). Thirty-four percent of children received combination therapy; the median number of antihypertensive drugs was 1.5 drugs/patient (range 14). Sixty-eight percent of children had

Název v anglickém jazyce

Long-Term Control of Ambulatory Hypertension in Children: Improving With Time But Still Not Achieving New Blood Pressure Goals

Popis výsledku anglicky

Short-term therapy can decrease blood pressure (BP) to less than the 95th percentile in only about 50% of children. The aim of our study was to investigate the long-term control of hypertension (HT) in children using ambulatory BP monitoring (ABPM). We analyzed data from all children who started ramipril monotherapy in our center. Controlled HT was defined according to the most current guidelines as systolic and diastolic BP at daytime and nighttime < 90th percentile in primary HT and < 75th percentilein renoparenchymal HT. Thirty-eight children who were on therapy 1 year were included. Thirty-two children had renoparenchymal, and 6 had primary HT. The median age at the beginning of therapy was 13.6 years (range 4.118.0 years), and the median time ofantihypertensive therapy was 2.6 years (range 1.011.8 years). Thirty-four percent of children received combination therapy; the median number of antihypertensive drugs was 1.5 drugs/patient (range 14). Sixty-eight percent of children had

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

<a href="/cs/project/ED2.1.00%2F03.0076" target="_blank" >ED2.1.00/03.0076: Biomedicínské centrum Lékařské fakulty v Plzni</a><br>

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

American Journal of Hypertension

ISSN

0895-7061

e-ISSN

—

Svazek periodika

26

Číslo periodika v rámci svazku

7

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

7

Strana od-do

939-945

Kód UT WoS článku

000320063500015

EID výsledku v databázi Scopus

—